Plinabulin is A More Favorable Option for the Prevention of Chemotherapy Induced Neutropenia (CIN) Than Pegfilgrastim During the COVID-19 Pandemic
A Single IV Dose of Plinabulin Induces Sustained Mobilization of CD34+ Cells in Humans Through A Mechanism of Action Independent From G-CSF or CXCR4 and Without Causing Bone Pain or Thrombocytopenia
Plinabulin, a Microtubule Destabilizing Agent, Improves Tumor Control by Enhancing Dendritic Cell Maturation and CD8 T Cell Infiltration in Combination with Immunoradiotherapy
Head-to-head Comparison of the Non-G-CSF Small Molecule Single Agent (SA) Plinabulin with SA Pegfilgrastim for the Prevention of Docetaxel Chemotherapy (Chemo)-Induced Neutropenia (CIN) in the PROTECTIVE-1 Trial
Plinabulin, a Potent Inducer of Haptoglobin Production for the Prevention of Tissue Iron Overload in Patients Receiving Blood Transfusions Chronically
© 2020 BeyondSpring Inc. All rights reserved.